Life Sciences Group Of The Year: Morrison Foerster
Morrison Foerster LLP successfully beat a preliminary injunction that would have thwarted a Sandoz biosimilar for multiple sclerosis from going to market, one achievement among many that earned the firm a...To view the full article, register now.
Already a subscriber? Click here to view full article